Chris Frampton

424 total citations
11 papers, 281 citations indexed

About

Chris Frampton is a scholar working on Surgery, Infectious Diseases and Orthopedics and Sports Medicine. According to data from OpenAlex, Chris Frampton has authored 11 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 2 papers in Infectious Diseases and 2 papers in Orthopedics and Sports Medicine. Recurrent topics in Chris Frampton's work include Total Knee Arthroplasty Outcomes (4 papers), Orthopaedic implants and arthroplasty (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Chris Frampton is often cited by papers focused on Total Knee Arthroplasty Outcomes (4 papers), Orthopaedic implants and arthroplasty (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Chris Frampton collaborates with scholars based in New Zealand, Austria and Canada. Chris Frampton's co-authors include Alastair G. Rothwell, Gary J. Hooper, Nigel Gilchrist, R Sainsbury, Tom Inglis, David Kieser, Michael A. Williams, Philip Pattemore, Simon W. Young and Antonio Klasan and has published in prestigious journals such as Clinical Orthopaedics and Related Research, Vaccine and Journal of Shoulder and Elbow Surgery.

In The Last Decade

Chris Frampton

10 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Frampton New Zealand 6 197 112 95 28 24 11 281
Julien Dаrtus France 12 309 1.6× 61 0.5× 71 0.7× 23 0.8× 25 1.0× 65 420
B.J.A. Lankester United Kingdom 11 148 0.8× 33 0.3× 40 0.4× 24 0.9× 8 0.3× 19 237
Bart Stuyts Belgium 8 225 1.1× 136 1.2× 142 1.5× 7 0.3× 7 0.3× 14 342
K.A. Reilly United Kingdom 7 210 1.1× 112 1.0× 66 0.7× 21 0.8× 102 4.3× 10 316
Michael Symes Australia 9 195 1.0× 37 0.3× 164 1.7× 7 0.3× 11 0.5× 52 315
Justin A. Magnuson United States 10 182 0.9× 54 0.5× 57 0.6× 23 0.8× 3 0.1× 38 245
Masja Loogman Netherlands 4 141 0.7× 98 0.9× 372 3.9× 8 0.3× 9 0.4× 7 437
Michel van den Bekerom Netherlands 9 289 1.5× 42 0.4× 155 1.6× 18 0.6× 14 0.6× 19 411
Shawn Nguyen United States 8 347 1.8× 42 0.4× 88 0.9× 40 1.4× 50 2.1× 10 394
Katrin Karpinski Germany 11 261 1.3× 40 0.4× 72 0.8× 13 0.5× 39 1.6× 33 317

Countries citing papers authored by Chris Frampton

Since Specialization
Citations

This map shows the geographic impact of Chris Frampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Frampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Frampton more than expected).

Fields of papers citing papers by Chris Frampton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Frampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Frampton. The network helps show where Chris Frampton may publish in the future.

Co-authorship network of co-authors of Chris Frampton

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Frampton. A scholar is included among the top collaborators of Chris Frampton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Frampton. Chris Frampton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Frampton, Chris, Michael A. Williams, Reuben McGregor, et al.. (2023). Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort. Vaccine. 41(38). 5535–5544. 1 indexed citations
3.
Priddy, Frances, Michael A. Williams, Chris Frampton, et al.. (2022). Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults. Vaccine. 40(34). 5050–5059. 8 indexed citations
4.
Quayle, Jonathan, Antonio Klasan, Chris Frampton, & Simon W. Young. (2021). Do TKAs in Patients with Higher BMI Take Longer, and is the Difference Associated with Surgeon Volume? A Large-database Study from a National Arthroplasty Registry. Clinical Orthopaedics and Related Research. 480(4). 714–721. 2 indexed citations
5.
Frampton, Chris, et al.. (2018). Does Orthopaedic Training Compromise the Outcome in Knee Joint Arthroplasty?. Journal of surgical education. 75(5). 1292–1298. 19 indexed citations
6.
Wyatt, Michael, Chris Frampton, & Gary J. Hooper. (2017). Is stem design important in uncemented total hip replacement to decrease subsidence in obese patients?. Annals of Joint. 2. 50–50. 1 indexed citations
7.
Hooper, Gary J., et al.. (2014). Current trends and projections in the utilisation rates of hip and knee replacement in New Zealand from 2001 to 2026.. PubMed. 127(1401). 82–93. 87 indexed citations
8.
Inglis, Tom, et al.. (2012). Does Orthopedic Training Compromise the Outcome in Total Hip Arthroplasty?. Journal of surgical education. 70(1). 76–80. 20 indexed citations
9.
Frampton, Chris, et al.. (2011). Magnetic resonance imaging assessment of tibial tuberosity–trochlear groove distance: normal values for males and females. International Orthopaedics. 35(12). 1799–1803. 110 indexed citations
10.
Gilchrist, Nigel, et al.. (2005). Shared care between geriatricians and orthopaedic surgeons as a model of care for older patients with hip fractures.. PubMed. 118(1214). U1438–U1438. 29 indexed citations
11.
Frampton, Chris, et al.. (2004). Application of asthma action plans to childhood asthma: national survey repeated.. PubMed. 117(1196). U932–U932. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026